Viewing Study NCT06535802



Ignite Creation Date: 2024-10-26 @ 3:36 PM
Last Modification Date: 2024-10-26 @ 3:36 PM
Study NCT ID: NCT06535802
Status: RECRUITING
Last Update Posted: None
First Post: 2024-07-30

Brief Title: iCCaRE Consortium Pilot Project 1 Feasibility of a Point of Prostate Cancer Diagnosis Intervention for Newly Diagnosed Black Men
Sponsor: None
Organization: None

Study Overview

Official Title: iCCaRE Consortium Pilot Project 1 Feasibility of a Point of Prostate Cancer Diagnosis Intervention for Newly Diagnosed Black Men
Status: RECRUITING
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study is being done to determine the acceptance and effectiveness of a virtual robot assistant model at a urology clinic
Detailed Description: PRIMARY OBJECTIVES

I Plan and develop a PPCD iCCaRE ViRA model that will provide social determinants of health SDOH navigation services psycho-oncology support and emotional support using qualitative formative research

II Establish the acceptance and usability of the iCCaRE ViRA at a urology clinic among 50 Black men BM

OUTLINE This is an observational study Participants are assigned to 1 of 5 cohorts

COHORT I Consumer advocates attend a focus group on study

COHORT II Clinicians complete interviews on study

COHORT III iCCaRE project representatives test the virtual health intervention complete a survey and attend a focus group on study

COHORT IV Non iCCaRE affiliated member tests the virtual health intervention complete a survey and attends a focus group on study

COHORT V Patients complete surveys and participate in the virtual health intervention on study Patients complete survey and an interview during follow up

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None